Elevance Health, Inc. (LON:0HG8)
London · Delayed Price · Currency is GBP · Price in USD 374.80
-0.80 (-0.21%)
At close: Jan 9, 2026
Elevance Health Market Cap
Elevance Health has a market cap or net worth of 61.81 billion as of January 9, 2026. Its market cap has decreased by -10.08% in one year.
Market Cap
61.81B
Enterprise Value
79.35B
Revenue
144.93B
Ranking
n/a
PE Ratio
15.02
Stock Price
374.80
Market Cap Chart
Since October 30, 2001, Elevance Health's market cap has increased from 2.89B to 61.81B, an increase of 2,037.03%. That is a compound annual growth rate of 13.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 61.81B | 6.78% |
| Dec 31, 2025 | 57.88B | -15.30% |
| Dec 31, 2024 | 68.34B | -21.43% |
| Dec 29, 2023 | 86.98B | -14.45% |
| Dec 30, 2022 | 101.68B | 22.37% |
| Dec 31, 2021 | 83.09B | 42.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 220.48B |
| GSK plc | 75.67B |
| Haleon | 32.73B |
| Smith & Nephew | 10.69B |
| Convatec Group | 4.80B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.70B |